3% Sodium Chloride · SODIUM CHLORIDE 3 g/100mL · Injection, Solution · Intravenous · Becton Dickinson and Company
NDC 17271-0703-06 · 20 BAG in 1 CASE / 500 mL in 1 BAG · ANDA · View full market →
Only one company currently supplies this market — there is no backup if it stumbles. Historically, drugs in this position went on to a new shortage within 90 days about 1.5% of the time — roughly 10× the typical drug (0.1%).
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Not scored — fragility is computed for NADAC-priced NDCs.
sterile injectable · 13 Class I/II recall(s) in 12 months · OAI inspection at a producing facility (24 months)
For scale: the typical drug’s chance is about 0.1% — this one is 10× that.
Backtested statistical model over the whole market, not this package alone. Model details →
Establishments this product's FDA label declares, located via FDA registration data. How we built this →
There's no legal definition — it meets 1 of 6 public criteria. Why that matters →
No FDA shortage reports for this drug or its presentations.
No enforcement reports list this package NDC.
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Becton Dickinson and Company | SODIUM CHLORIDE 3 g/100mL | Jul 15, 2026 | Sep 2, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
DrugDashboards, "3% Sodium Chloride — NDC 17271-0703-06," retrieved September 3, 2026, https://drugdashboards.com/drug/17271070306.
Free to cite with attribution — see how the data is put together.